 Eliza Kramer
Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis | 18 | 2026 | 1161 | 3.010 |
Why?
| | Transforming Growth Factor beta | 5 | 2025 | 474 | 1.970 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2025 | 382 | 1.310 |
Why?
| | Lung | 9 | 2026 | 4106 | 1.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 5 | 2025 | 371 | 0.930 |
Why?
| | Goblet Cells | 4 | 2020 | 22 | 0.820 |
Why?
| | Bronchial Hyperreactivity | 4 | 2011 | 104 | 0.770 |
Why?
| | Dysgeusia | 1 | 2021 | 5 | 0.680 |
Why?
| | Interleukin-6 | 1 | 2025 | 776 | 0.670 |
Why?
| | Transforming Growth Factor alpha | 3 | 2011 | 55 | 0.630 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 65 | 0.610 |
Why?
| | Xenon Isotopes | 4 | 2025 | 7 | 0.540 |
Why?
| | Airway Remodeling | 3 | 2017 | 63 | 0.540 |
Why?
| | Hyperplasia | 4 | 2023 | 177 | 0.540 |
Why?
| | Extracellular Traps | 3 | 2023 | 52 | 0.530 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2018 | 177 | 0.510 |
Why?
| | Quinolones | 3 | 2026 | 203 | 0.500 |
Why?
| | Asthma | 4 | 2023 | 1797 | 0.500 |
Why?
| | Drug Design | 1 | 2017 | 175 | 0.490 |
Why?
| | Signal Transduction | 7 | 2025 | 5216 | 0.470 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 561 | 0.460 |
Why?
| | Magnetic Resonance Imaging | 5 | 2026 | 3904 | 0.450 |
Why?
| | Muscle, Smooth | 4 | 2023 | 153 | 0.420 |
Why?
| | Mental Disorders | 1 | 2023 | 1163 | 0.400 |
Why?
| | Sirolimus | 2 | 2011 | 280 | 0.380 |
Why?
| | Early Growth Response Protein 1 | 2 | 2011 | 32 | 0.380 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 322 | 0.350 |
Why?
| | MicroRNAs | 1 | 2018 | 686 | 0.340 |
Why?
| | Aminopyridines | 2 | 2025 | 129 | 0.340 |
Why?
| | Gene Expression Regulation | 3 | 2020 | 2597 | 0.330 |
Why?
| | Epithelial Cells | 4 | 2025 | 1131 | 0.320 |
Why?
| | Environmental Exposure | 2 | 2025 | 578 | 0.310 |
Why?
| | Benzodioxoles | 2 | 2025 | 161 | 0.310 |
Why?
| | Aminophenols | 2 | 2025 | 202 | 0.300 |
Why?
| | Respiratory Function Tests | 3 | 2026 | 544 | 0.280 |
Why?
| | Spirometry | 3 | 2026 | 233 | 0.260 |
Why?
| | Albuterol | 3 | 2020 | 76 | 0.260 |
Why?
| | Mice | 9 | 2025 | 18329 | 0.250 |
Why?
| | Pulmonary Alveoli | 2 | 2024 | 385 | 0.250 |
Why?
| | Lung Diseases | 2 | 2024 | 780 | 0.250 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2188 | 0.250 |
Why?
| | Animals | 12 | 2025 | 38030 | 0.240 |
Why?
| | ErbB Receptors | 4 | 2011 | 635 | 0.240 |
Why?
| | Mucus | 1 | 2026 | 75 | 0.230 |
Why?
| | Pulmonary Fibrosis | 1 | 2009 | 395 | 0.220 |
Why?
| | Bayes Theorem | 2 | 2024 | 420 | 0.210 |
Why?
| | Disease Progression | 3 | 2025 | 2864 | 0.190 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2024 | 155 | 0.190 |
Why?
| | Interleukin-8 | 2 | 2023 | 269 | 0.190 |
Why?
| | Psychopathology | 1 | 2023 | 54 | 0.190 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2025 | 638 | 0.190 |
Why?
| | Humans | 25 | 2026 | 145475 | 0.180 |
Why?
| | Bronchi | 2 | 2023 | 263 | 0.180 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 5983 | 0.180 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2007 | 411 | 0.170 |
Why?
| | Acid Ceramidase | 1 | 2020 | 2 | 0.160 |
Why?
| | Mouth | 1 | 2021 | 86 | 0.160 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4560 | 0.160 |
Why?
| | Bronchoconstriction | 1 | 2020 | 29 | 0.160 |
Why?
| | Child | 10 | 2025 | 22707 | 0.160 |
Why?
| | Adolescent | 10 | 2025 | 22530 | 0.160 |
Why?
| | Sphingolipids | 1 | 2020 | 83 | 0.150 |
Why?
| | Adrenergic beta-Agonists | 1 | 2020 | 92 | 0.150 |
Why?
| | Taste | 1 | 2021 | 238 | 0.140 |
Why?
| | Pseudomonas Infections | 1 | 2020 | 230 | 0.140 |
Why?
| | Transforming Growth Factors | 1 | 2018 | 3 | 0.140 |
Why?
| | Executive Function | 1 | 2023 | 470 | 0.140 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 26 | 0.130 |
Why?
| | Transduction, Genetic | 1 | 2018 | 132 | 0.130 |
Why?
| | Pessimism | 1 | 2017 | 9 | 0.130 |
Why?
| | Rumination, Cognitive | 1 | 2017 | 11 | 0.130 |
Why?
| | Anisocoria | 1 | 2017 | 3 | 0.130 |
Why?
| | Adenoviridae | 1 | 2018 | 199 | 0.130 |
Why?
| | Sleep Apnea, Central | 1 | 2017 | 13 | 0.130 |
Why?
| | Hypoventilation | 1 | 2017 | 17 | 0.130 |
Why?
| | Thinking | 1 | 2017 | 63 | 0.120 |
Why?
| | Self Efficacy | 1 | 2020 | 410 | 0.120 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 497 | 0.120 |
Why?
| | Interleukin-1 | 1 | 2020 | 961 | 0.120 |
Why?
| | Patient Compliance | 1 | 2020 | 587 | 0.120 |
Why?
| | Hirschsprung Disease | 1 | 2017 | 92 | 0.110 |
Why?
| | Male | 12 | 2026 | 72843 | 0.110 |
Why?
| | Female | 13 | 2026 | 78845 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 439 | 0.110 |
Why?
| | Pneumonia | 1 | 2020 | 636 | 0.110 |
Why?
| | Cognition | 1 | 2023 | 1266 | 0.110 |
Why?
| | Attention | 1 | 2017 | 461 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2017 | 314 | 0.100 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 523 | 0.100 |
Why?
| | Mice, Knockout | 2 | 2011 | 3124 | 0.090 |
Why?
| | Decision Making | 1 | 2020 | 977 | 0.090 |
Why?
| | Inflammation | 3 | 2020 | 2878 | 0.090 |
Why?
| | Leukocyte Elastase | 2 | 2023 | 75 | 0.090 |
Why?
| | Parents | 1 | 2020 | 1403 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2011 | 454 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 14219 | 0.080 |
Why?
| | Mental Health | 1 | 2017 | 793 | 0.080 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2023 | 253 | 0.080 |
Why?
| | Cell Line | 3 | 2023 | 2823 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2011 | 315 | 0.080 |
Why?
| | Anxiety | 1 | 2017 | 1118 | 0.080 |
Why?
| | Methacholine Chloride | 1 | 2009 | 51 | 0.070 |
Why?
| | Lung Compliance | 1 | 2009 | 42 | 0.070 |
Why?
| | Airway Resistance | 1 | 2009 | 38 | 0.070 |
Why?
| | Transcription Factors | 1 | 2017 | 1734 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2020 | 4148 | 0.070 |
Why?
| | Transcription, Genetic | 2 | 2020 | 1454 | 0.060 |
Why?
| | Adult | 7 | 2026 | 40777 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2025 | 2953 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2007 | 156 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 838 | 0.060 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2009 | 449 | 0.060 |
Why?
| | Organ Size | 1 | 2007 | 461 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 1 | 2009 | 666 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 1997 | 0.060 |
Why?
| | Chloride Channel Agonists | 1 | 2026 | 109 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2025 | 3623 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 749 | 0.050 |
Why?
| | Prospective Studies | 3 | 2025 | 8057 | 0.050 |
Why?
| | Blotting, Western | 2 | 2020 | 1179 | 0.050 |
Why?
| | Salamandridae | 1 | 2004 | 33 | 0.050 |
Why?
| | Models, Biological | 1 | 2011 | 1764 | 0.050 |
Why?
| | Drug Combinations | 1 | 2025 | 396 | 0.050 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2023 | 90 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2011 | 2803 | 0.050 |
Why?
| | Protease Inhibitors | 1 | 2023 | 102 | 0.050 |
Why?
| | Fibroblasts | 1 | 2009 | 1025 | 0.050 |
Why?
| | Healthy Volunteers | 1 | 2023 | 219 | 0.050 |
Why?
| | Weight Loss | 1 | 2009 | 858 | 0.050 |
Why?
| | Body Weight | 1 | 2007 | 971 | 0.050 |
Why?
| | Pulmonary Artery | 1 | 2009 | 1127 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2026 | 17291 | 0.050 |
Why?
| | Lens, Crystalline | 1 | 2004 | 136 | 0.050 |
Why?
| | Regeneration | 1 | 2004 | 197 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2007 | 910 | 0.040 |
Why?
| | Myocardium | 1 | 2007 | 934 | 0.040 |
Why?
| | Trans-Activators | 1 | 2004 | 396 | 0.040 |
Why?
| | Pyroglyphidae | 2 | 2011 | 18 | 0.040 |
Why?
| | Cadherins | 1 | 2023 | 200 | 0.040 |
Why?
| | Air Pollution | 1 | 2024 | 314 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2026 | 11772 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 2020 | 87 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1767 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2121 | 0.040 |
Why?
| | Air Pollutants | 1 | 2024 | 405 | 0.040 |
Why?
| | Alveolar Epithelial Cells | 1 | 2020 | 121 | 0.040 |
Why?
| | Peroxidase | 1 | 2020 | 168 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2007 | 2046 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 500 | 0.040 |
Why?
| | Rats | 1 | 2007 | 5584 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 372 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1041 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2020 | 730 | 0.030 |
Why?
| | Cyclic AMP | 1 | 2018 | 207 | 0.030 |
Why?
| | DNA | 1 | 2023 | 1435 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2020 | 506 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2017 | 129 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1368 | 0.030 |
Why?
| | Drug Interactions | 1 | 2018 | 405 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1547 | 0.030 |
Why?
| | Cilia | 1 | 2018 | 173 | 0.030 |
Why?
| | Siblings | 1 | 2017 | 196 | 0.030 |
Why?
| | Mutation | 2 | 2018 | 4075 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2020 | 910 | 0.030 |
Why?
| | Heterozygote | 1 | 2017 | 313 | 0.030 |
Why?
| | Neural Crest | 1 | 2017 | 129 | 0.030 |
Why?
| | Pedigree | 1 | 2017 | 515 | 0.030 |
Why?
| | Exons | 1 | 2017 | 363 | 0.030 |
Why?
| | Face | 1 | 2017 | 174 | 0.030 |
Why?
| | Neuroimaging | 1 | 2017 | 297 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2007 | 6447 | 0.030 |
Why?
| | Child, Preschool | 2 | 2020 | 11853 | 0.030 |
Why?
| | Electroencephalography | 1 | 2017 | 561 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1716 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2930 | 0.020 |
Why?
| | Databases, Factual | 1 | 2017 | 1490 | 0.020 |
Why?
| | Metaplasia | 1 | 2010 | 57 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 337 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 305 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 36215 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 762 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1261 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3155 | 0.020 |
Why?
| | Hypersensitivity | 1 | 2011 | 254 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1162 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 7123 | 0.020 |
Why?
| | Chronic Disease | 1 | 2010 | 1808 | 0.010 |
Why?
| | Patched Receptors | 1 | 2004 | 14 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2004 | 77 | 0.010 |
Why?
| | Cytokines | 1 | 2011 | 2067 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2004 | 318 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 505 | 0.010 |
Why?
| | Hedgehog Proteins | 1 | 2004 | 200 | 0.010 |
Why?
| | Infant | 1 | 2017 | 10077 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 977 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 372 | 0.010 |
Why?
| | RNA | 1 | 2004 | 910 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2004 | 1164 | 0.010 |
Why?
| | Aged | 1 | 2017 | 26153 | 0.010 |
Why?
|
|
Kramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|